Advertisement
Advertisement
CRL
Charles River Laboratories International, Inc.
160.30
USDSponsored
+1.44
+0.91%
May 22, 16:00 UTC -4
Closed
After-Market
160.31
+0.01
+0.01%
CRL Earnings Reports
Positive Surprise Ratio
CRL beat 41 of 41 last estimates.
100%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$983.11M
/$2.75
Implied change from Q1 26 (Revenue/ EPS)
-1.28%
/+33.50%
Implied change from Q2 25 (Revenue/ EPS)
-4.75%
/-11.86%
Charles River Laboratories International, Inc. earnings per share and revenue
On May 07, 2026, CRL reported earnings of 2.06 USD per share (EPS) for Q1 26, beating the estimate of 1.96 USD, resulting in a 4.98% surprise. Revenue reached 995.83 million, compared to an expected 987.26 million, with a 0.87% difference. The market reacted with a -0.03% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of 2.75 USD, with revenue projected to reach 983.11 million USD, implying an increase of 33.50% EPS, and decrease of -1.28% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enhabit, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
$0.15
Actual
-Surprise
-
COMPASS Pathways Plc - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.38
Actual
-$0.30
Surprise
+22.20%
Auna S.A.
Report Date
May 19, 2026 For Q1 26
Estimate
$0.88
Actual
$0.17
Surprise
-80.69%
SBC Medical Group Holdings Incorporated Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.09
Actual
$0.11
Surprise
+11.11%
Forward Industries, Inc. Common Stock
Report Date
May 14, 2026 For Q2 26
Estimate
-$0.03
Actual
$0.04
Surprise
+230.72%
Shoulder Innovations, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.42
Actual
-$0.41
Surprise
+3.10%
So-Young International Inc. - ADR
Report Date
May 22, 2026 For Q1 26
Estimate
-$0.74
Actual
-$0.47
Surprise
+36.22%
Lifeward Ltd. Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$1.28
Actual
-$3.13
Surprise
-144.51%
Aclarion, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$1.58
Actual
-$1.34
Surprise
+15.24%
Synergy CHC Corp. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.03
Actual
-$0.23
Surprise
-744.26%
FAQ
What were Charles River Laboratories International, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Charles River Laboratories International, Inc. reported EPS of $2.06, beating estimates by 4.98%, and revenue of $995.83M, 0.87% above expectations.
How did the market react to Charles River Laboratories International, Inc.'s Q1 2026 earnings?
The stock price moved down -0.03%, changed from $181.73 before the earnings release to $181.68 the day after.
When is Charles River Laboratories International, Inc. expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Charles River Laboratories International, Inc.'s next earnings report?
Based on 13
analysts, Charles River Laboratories International, Inc. is expected to report EPS of $2.75 and revenue of $983.11M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement